Breakthrough

A single jab hailed as a ‘potential cure’ for type 1 diabetes will be trialled this year – raising hopes it could finally end the need for multiple daily insulin …

NEW YORK, Feb. 9, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is proud to announce Land O’Frost, a third-generation, …

Breakthrough T1DSpotlight on OPF-310: A porcine-derived cell therapy in clinical trialsOne of our most promising avenues toward cures for type 1 diabetes is cell therapies. Learn more about one of …

Breakthrough T1DCongress Passes Bipartisan Extension of the Special Diabetes Program, Securing Critical T1D Research FundingCongress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone …

Breakthrough T1D“Do good, feel good”: Alecia Wesner’s T1D clinical trial journeyAs a Participant Advisory Council member, Alecia Wesner shares her lived experience with type 1 diabetes and clinical trials..7 hours …

NEW YORK, Jan. 29, 2026 /PRNewswire/ — Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to recognize the generosity of Ford …

Grant will strengthen insurance and Medicaid navigation and continuity of care for adults living with T1D NEW YORK, Jan. 15, 2026 /PRNewswire/ — Breakthrough T1D, the leading global type 1 …

A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill that lowers blood sugar and boosts fat burning without …

Apple Watch glucose monitoring has taken a significant step forward with recent developments that could reshape how millions manage their blood sugar levels. When the Apple Watch first launched back …

BUENOS AIRES, Dec. 4 (UPI) — Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door …